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Infantile myoﬁbromatosis (IM) is a rare disorder characterized by the development of benign tumors in
the skin, muscle, bone, and viscera. The incidence is 1/150,000 live births and the disease is the most
common cause of ﬁbrous tumors in infancy. Cases which lack visceral involvement generally have a more
benign course, usually with spontaneous regression of the tumors. On the other hand, the prognosis
tends to be unfavorable when there is involvement of vital organs, which can lead to signiﬁcant
mortality.
The identiﬁcation of rare variants in genes that may cause IM is the ﬁrst step towards the possibility of
targeted treatments; however, the molecular pathogenesis of IM is poorly understood. In the present
study, we report the results of exome sequence analysis of two brothers diagnosed with visceral mul-
ticentric infantile myoﬁbromatosis, and their healthy consanguineous parents. In the two brothers we
identiﬁed novel homozygous variants in NDRG4 gene (N-myc downregulated gene family member 4) and
in RLTPR gene (RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing). The
healthy parents were heterozygous for both variants. Consistent with the phenotype of IM, NDRG4 is a
tumor-related gene; its expression has been shown to be decreased in numerous tumor types, suggesting
that it might be a tumor suppressor gene. Additionally, studies have demonstrated that NDRG4 may have
a role in cell survival and tumor invasion. We thus propose that this homozygous variant in NDRG4 may
be the causative variant of the autosomal recessive form of IM in the studied family and that it should be
investigated in other cases of autosomal recessive infantile myoﬁbromatosis.
 2014 Elsevier Masson SAS. All rights reserved.1. Introduction
Infantile myoﬁbromatosis (IM; OMIM 228550 and 615293) is a
rare disorder characterized by the development of benign tumors
in soft tissues and striated muscles, involving occasionally visceral
organs and bones. The tumors are present at birth or develop
shortly thereafter, with 90% of cases occurring before two years of
age [Orbach, 2013]. The incidence is 1/150,000 live births, although
this condition is the most common cause of ﬁbrous tumors in
infancy [Orbach, 2013; Wiswell et al., 1988]. Stout [1954] ﬁrstMinas Gerais, Faculdade de
nta Eﬁgênia, 30130-100 Belo
erved.described this entity based on histology and suggested the term
“congenital generalized ﬁbromatosis”. Years later, Chung and
Enzinger [1981], noted that these benign tumors consist of cells
that have morphological characteristics of both smooth muscle
and ﬁbroblasts, and they renamed the disease “infantile
myoﬁbromatosis”.
Infantile myoﬁbromatosis may occur as one of two forms: soli-
tary lesions or multicentric tumors. The former tend to occur in
skin, especially in the soft tissues of the head and neck, followed by
the upper extremities and trunk. The latter is characterized by
multiple nodules in soft tissues, skeleton and internal organs
[Tamburrini et al., 2003]. Infants with a solitary lesion, or with
multiple lesions but without visceral involvement, generally have
a benign course, frequently with spontaneous regression of the
tumors [Huang et al., 2005]. On the other hand, the prognosis
tends to be unfavorable when there is involvement of the
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can be as high as 73% [Wiswell et al., 1988]. The treatment of
choice for cases that affect the vital functions has been surgical
excision [Gatibelza et al., 2012]. In aggressive cases,
chemotherapy and corticosteroids have been used as therapeutic
strategies e nevertheless, the literature is unclear about the
overall success of such treatments [Gandhi et al., 2003].
Little is known about the molecular pathogenesis of IM.
Although most reported cases are simplex, both autosomal reces-
sive and dominant inheritance have been reported in multiplex
cases [Zand et al., 2004]. Recently, variants in the genes PDGFRB
(platelet-derived growth factor receptor, beta polypeptide; OMIM
173410) and NOTCH3 (notch 3; OMIM 600276) have been
reported as being the cause of the autosomal dominant forms of
IM [Cheung et al., 2013; Martignetti et al., 2013].
In this report we describe the results of exome sequence anal-
ysis of two brothers diagnosed with multicentric IM and their
consanguineous healthy parents. We suggest that the variant
c.511G>C (p.Val171Leu) in the gene NDRG4 (N-myc downregulated
gene family member 4; OMIM 614463) present in homozygosity in
the two brothers and in heterozygozity in their parents is a strong
candidate to be the causative variant in this family.
2. Clinical report
2.1. The family
The studied family is composed of four individuals; both sons
are affected with multicentric infantile myoﬁbromatosis. The par-
ents are healthy and report distant consanguinity.
2.2. Proband
The patient was ﬁrst seen at the Pediatric Clinic of Hospital
das Clínicas of UFMG at age ﬁve. The history had been healthy
until 12 months of age, when he presented recurrent abdominal
pain and chronic diarrhea. At four years, cow’s milk was
substituted by milk based on soy; however the symptoms were
not eliminated.
From then on his growth was slow; at eight years of age his
weight was 14 kg and height 105 cm (both below the 3rd centile).
Colonoscopy detected ulcerations and polyps suggestive of sub-
epithelial lesions and raising the clinical suspicion of inﬂamma-
tory bowel disease. He was thus treated with sulfasalazine and
prednisone, with improvement of the abdominal pain. The dose of
corticoid was then tapered down and ﬁnally the drug was stopped,
which was followed by recurrence of the abdominal pain. Another
colonoscopy was performed at nine years and showed multiple
subepithelial lesions with a central ulceration, some of them with
ﬁbrin. Video capsule endoscopy showed two lesions with 4 mm
and 7 mm in the jejunum, which were described in detail in a
previously publication about the case [Alberti et al., 2012].Fig. 1. Hematoxylin and eosin (H&E) stained sections of the tumor. (A) Bowel biopsy at magn
left side. (B) Lung biopsy at 100magniﬁcation showing alveolar septum at right of the ﬁgur
was composed of spindle cells, which resembled normal smooth muscle and ﬁbroblast celBiopsies were taken from the colonic lesions and a pathological
diagnosis of infantile myoﬁbromatosis was made. H&E stained
sections showed that the tumors were composed of
myoﬁbroblasts (Fig. 1). Immunohistochemistry demonstrated
that the tissue was immunoreactive for vimentin, actin and
desmin but were uniformly negative for the vascular markers,
CD34 and S-100.
Also at nine years of age, the patient was hospitalized twicewith
pneumonia. Chest computed tomography showed eleven bilateral
pulmonary nodules (measuring 2.0 mme1.1 cm), mediastinal
lymphadenomegaly and a tissue mass inﬁltrating the bronchus to
the lower lobe of the left lung. This mass also inﬁltrated the left
inferior pulmonary vein, leading the inference that it was probably
a neoplastic lesion. The abdominopelvic CT Scan showed a rounded
lesion with well-deﬁned edges, located at the liver, measuring
approximately 2.1  1.9 cm, solid nodular lesions attached to the
walls of the descending and sigmoid colon, cholecystolithiasis and
nephrolithiasis. The patient underwent left lower lobectomy.
Pathological analysis of the product of the resection showed myo-
ﬁbroblastic proliferation (Fig. 1B), bronchiectasis and
bronchopneumonia. Immunohistochemistry conﬁrmed the
diagnosis of infantile myoﬁbromatosis.2.3. Proband’s brother
This second patient, proband’s brother, was ﬁrst seen at the
Pediatric Clinic of Hospital das Clínicas of UFMG at six years of age
because of crusty skin lesions in the trunk, head segment, scalp,
upper and lower limbs, which had begun to appear since one year
of age, diagnosed as seborrheic dermatitis.
Total abdominal ultrasonography was performed because of his
brother diagnosis and showed at least four hepatic nodules and in
the hepatic hilum. Esophagus, stomach and duodenum were
normal at endoscopy. Colonoscopy showed indurated lesions with
subepithelial aspect with erosion and apical ulcerations of various
sizes located in all colonic segments, with endoscopic appearance
suggestive of infantile myoﬁbromatosis. Presently, at age nine, his
weight and height are below the 3rd percentile. He has had a good
performance in school.3. Methods
3.1. Samples and DNA isolation
This study was approved by the Research Ethics Committee of
the Universidade Federal de Minas Gerais. The written informed
consent was undersigned by participants and/or their caretakers.
Genomic DNA was isolated from peripheral blood of the patients
and their parents using a modiﬁed salting out procedure [Miller
et al., 1988].iﬁcation of 100 showing intestine villi at right of the ﬁgure and myoﬁbroblasts at the
e and myoﬁbroblasts at the left side. (C) Tumor at magniﬁcation of 400 showing that it
ls arranged in a whorled and fascicular pattern.
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Genotyping on the Affymetrix Genome-Wide Human SNP Array
6.0 was performed at Aros Applied Biotechnology, Aarhus, Denmark.
3.3. Exome sequencing and analysis
Exome sequencing was performed in samples from the two
brothers and their healthy parents by The Centre for Applied Ge-
nomics, The Hospital for Sick Children, Toronto, Canada using the
Agilent SureSelect Human All Exon V4 Kit (Agilent Technologies),
which targeted 20,965 genes and 334,378 exons. Enriched genomic
DNA was massively parallel sequenced on the SOLiD 5500xl
(Applied Biosystems). Approximately 130 million of 75 bp  35 bp
paired-end reads per individual were returned. The average
coverage was 103-fold, with circa 96% of the target bases being
covered at least at 10 (Table 1). All data were aligned to the
GRCh37/hg19 reference genome build via BFAST and BWA aligner.
Variants were quality trimmed using Genome Analysis Toolkit
(GATK 1.1.28) and they were annotated for functional effect by
SnpEff 2.0.5. Alignment, calling and annotation of the variants
against databases such as 1000 Genomes (April 2012 release),
NHLBI Exome Sequencing Project (ESP6500) and Single
Nucleotide Polymorphism database (dbSNP137) were done using
a software developed in-house called Mendel,MD (RGCCL Carde-
nas and SDJ Pena, manuscript in preparation).
3.4. Sanger sequencing
Sanger sequencing was performed for validation of the variants
of interest identiﬁed in exome analysis using the BigDye Terminator
v3.1 Cycle Sequencing Kit (Applied Biosystems) and the Applied
Biosystems (ABI) 3130 Genetic Analyzer. Sequencing data was
analyzed using the software Sequencher version 4.1.4 (Genes Code
Corporation).
4. Results
Analysis of the Affymetric 6.0 SNP-array genotype data of the
patients and their parents did not show presence of any micro-
deletions or microduplications. A coefﬁcient of genetic relationship
of 0.0134was estimated between the two parents using the software
IBDelphi [Carr et al., 2011], conﬁrming the history of consanguinity.
Over 80,000 variants were identiﬁed in each individual by
exome sequencing. Approximately 14,000 of these variants passed
in the GATK quality ﬁlters and had a Minor Allele FrequencyTable 1
Summary of exome sequencing data for each sample.
1st son 2nd son Father Mother
Total captured regions size 51 Mb 51 Mb 51 Mb 51 Mb
% of captured regions
with coverage >10
96.2% 95.8% 96.2% 96.4%
Average coverage of
captured region ()
107 96 102 107
Total number of SNPs 77,154 77,482 76,566 79,324
Total number of INDELs 6743 6562 6705 6965
N rare homozygous
(n conﬁrmed by Sanger)a
694 (1) 785 (1) 767 (0) 616 (0)
N compound heterozygous
(n conﬁrmed by Sanger)a
754 (0) 1029 (0) e e
N X linked (n conﬁrmed by Sanger)a 61 (0) 53 (0) e e
N de novo events
(n conﬁrmed by Sanger)a
4253 (0) 8615 (0) e e
Frequency [MAF]  0.03 in the 1000 Genomes and ESP6500.
a Only considered variants which passed in GATK quality ﬁlters and with Minor
Allele.(MAF)  0.03 in the 1000 Genomes and ESP6500 (Supplementary
Table 1). For the ﬁltering process we had to test different
inheritance models. The fact that both parents were
phenotypically normal and that two children are affected
rendered dominant inheritance (autosomal or X-linked) unlikely.
We ﬁrst tested an X-linked recessive inheritance. For that, var-
iants were narrowed down using ﬁve consecutive ﬁlters: (1) vari-
ants on the X chromosome hemizygous in the patients,
heterozygous in the mother and not present in the father; (2) var-
iants which passed in GATK quality ﬁlters; (3) variants with read
depth > 10; (4) rare variants in the population (MAF  0.005 in the
1000 Genomes, ESP6500 and dbSNP137); (5) variants with impact
moderate or high by SnpEff. None of the variants were predicted as
deleterious. i.e., all had SIFT score above 0.05.
We then tested the autosomal recessive model of inheritance,
which received support from the presence of distant consanguinity
between the parents. Variants were narrowed down using the
previously described ﬁve consecutive ﬁlters except for the ﬁrst of
them, which was replaced by “variants homozygous in the patients
and heterozygous in the parents” (Fig. 2). It resulted in the
identiﬁcation of candidate variants in two genes: NDRG4 and
RLTPR (OMIM 610859). The brothers were homozygous for both
variants and the healthy parents were heterozygous (Table 2).
The variant in RLTPR (NM_001013838.1; Chr16:67681506;
Intron 11; c.871þ1G>T) was a splice site donor mutation. This gene
has 12 transcripts described in Ensembl Genome Browser (splice
variants). However, none of them retained the intron 11. Alignment
of RLTPR orthologues weremade using the software Alamut version
2.4.5 (Interactive Biosoftware) and showed that the variant is
located in a region not well conserved throughout evolution
(Fig. 3A). This variant had not been described previously by the
1000 Genomes Project, ESP6500 and dbSNP137.
The variant inNDRG4 (NM_001130487.1; Chr16:58538536; Exon
9; c.511G>C) was a missense substitution of p.Val171Leu. The
variant is located in a well conserved region throughout evolution
in NDRG4 orthologues; except for the Drosophila melanogaster and
Caenorhabditis elegans sequences (Fig. 3B). The variant in NDRG4
was validated by Sanger sequencing in samples from the parents
and both brothers (Fig. 4A). It was predicted to be deleterious by
SIFT (score 0.00), possibly damaging by PolyPhen-2 (score 0.717)
and disease causing by Mutation Taster (p-value 1.00). This variant
also had not been described in the previously described databases.
Additionally, this G/C variant had not been seeing in any of TCAG’s
exome or whole genome databases, consisting of 436 autism
samples sequenced on SOLiD, 1083 whole genome samples
sequenced by Complete Genomics, 37 Clinical exome samples on an
Illumina HiSeq platform and 80 samples sequenced on an Illumina
HiSeq platform. However, a heterozygous G/A variant had been
detected in one Complete Genomics samples.
Autozygosity mapping was performed on the exome sequence
data of the children and their parents using AgileGenotyper and
AgileVariantMapper [Carr et al., 2013]. It revealed a large run of
homozygosity at chromosome 16 extended from 58,319,834 to
70,680,838 in the ﬁrst son and from 58,319,950 to 71,101,288 in
the second son (hg19). Interestingly, this autozygous region is
exclusively shared by the affected brothers and includes the
NDRG4 gene (which is located at chr16:58,497,548e58,547,522)
and the RLTPR gene (chr16:67,679,029e67,691,471) (Fig. 4B).
5. Discussion
In the present study, exome sequencing identiﬁed novel ho-
mozygous variants in NDRG4 and RLTPR in two brothers described
herein with multicentric IM. The NDRG4 gene seems to be the
better candidate as discussed below.
Fig. 2. Illustration of the analysis method using progressive ﬁlters. Candidate variants were narrow down using ﬁve consecutive ﬁlters based on autosomal recessive model of
inheritance. *Minor allele frequency [MAF]  0.005 in the 1000 Genomes, ESP6500 and dbSNP137.
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(LRRs) family with a RGD motif, a tropomodulin region and a
proline-rich domain [Matsuzaka et al., 2004]. Its function is unclear,
but it might be involved with T cell-dependent autoimmunity: itsTable 2
Details of the variants narrowed down using consecutive ﬁlters based on autosomal
recessive model of inheritance.
Chromosome chr16 chr16
Position 58538536 67681506
Gene name NDRG4 RLTPR
Reference G G
Number of reads with reference
1st SON
3 1
Alternative 1st SON C T
Number of reads with alternative
1st SON
126 111
Number of reads with reference
2nd SON
2 6
Alternative 2nd SON C T
Number of reads with alternative
2nd SON
98 101
Number of reads with reference
MOTHER
66 65
Alternative MOTHER C T
Number of reads with alternative
MOTHER
38 54
Number of reads with reference
FATHER
60 63
Alternative FATHER C T
Number of reads with alternative
FATHER
55 49
Mutation type Missense Intron
Refseq NM_001130487.1 NM_001013838.1
Mutation DNA
(HGVS nomenclature_c.)
c.511G>C c.871þ1G>T
Mutation protein
(HGVS nomenclature_p.)
p.Val171Leu unknown
Prediction from (SIFT, Polyphen2,
Mutation Taster, etc.)
SIFT: Deleterious
PP2: Possibly
damaging
Mutantion Taster:
Disease causing
Not predicted
Sanger veriﬁcation YES NOexpression had been shown to be downregulated in psoriatic skin
and it had been demonstrated that in the mouse, the protein Rltpr
is essential for costimulation via CD28 and the development of
regulatory T cells [Liang et al., 2013; Matsuzaka et al., 2004].
Additionally, expression of Rltpr had been detected exclusively in
lymphoid tissues [Liang et al., 2013].
On the other hand, NDRG4 is a member of the N-myc down-
regulated gene family (NDRG), which is composed of four members
named NDRG1-4. The isoforms of NDRG4 mRNA in human organ-
s/tissues had been identiﬁed exclusively in the brain and heart
[Reviewed by Yang et al., 2013]. Consistent with the phenotype of
IM, NDRG4 is a tumor-related gene; expression of NDRG4 has
been shown to be decreased in numerous cancer cell lines and
tumor types, such as in human gliomas and colorectal cancer tissue,
suggesting that it may exert function as a tumor suppressor gene in
these tissues [Reviewed by Yang et al., 2013]. Furthermore, it had
been demonstrated that NDRG4 has roles in aggressive aspects of
the tumor biology such as colony formation, cell proliferation and
tumor invasion [Reviewed by Yang et al., 2013].
Nishimoto et al., [2003] demonstrated that NDRG4 (also known
as SMAP8) is involved in the regulation of mitogenesis via MAPK
signaling in aortic smooth muscles cells (A10 cells) of rats. The
authors demonstrated that smap8 overexpression decreased
during proliferation and migration of A10 cells, whereas the
sensitivity to platelet-derived growth factor (PDGF) was
enhanced. Prior to ERK1/2 activation, smap8 protein was phos-
phorylated by the staurosporine-sensitive kinase, which is specif-
ically activated by PDGF.
Remarkably in line with our results, variants in PDGFRB and
NOTCH3were recently relatedwith the autosomal dominant form of
IM [Cheung et al., 2013; Martignetti et al., 2013]. Similarly to NDRG4,
PDGFRB promotes growth of mesenchymal cells, including blood
vessels and smooth muscles, which are affected in IM. In addition,
the expression of PDGFRB is regulated by NOTCH signaling in
vascular smooth muscle cells [Jin et al., 2008]. Moreover, as
previously described, there is a functional association between the
NDRG4 gene and PDGF, suggesting that these variants are possibly
involved in the same pathway leading to IM.
In conclusion, our ﬁndings suggest that variants in NDRG4 may
be involved with the autosomal recessive form of IM. The variant in
Fig. 3. Comparative analysis using RLTPR and NDRG4 orthologs. Alignments of RLTPR and NDRG4 orthologues were made with software Alamut 2.4.5. The positions of the variants were indicated by the red arrows. (A) Part of the RLTPR
protein is shown. (B) Part of the NDRG4 protein showing that, on the contrary of the variant in RLTPR, the variant in NDRG4 is located in a region well conserved throughout evolution. Fully conserved amino acids are marked in dark
blue and less-conserved amino acids are in lighter blue colors. Species name are as follows: Bos taurus (cow), Caenorhabditis elegans (C. elegans), Callithrix jacchus (white-tuffed-ear marmoset), Canis familiaris (dog), Drosophila
melanogaster (fruitﬂy), Felis catus (cat), Gallus gallus (chicken), Gorilla gorilla (gorilla), Homo sapiens (human), Mus musculus (mouse), Pan troglodytes (chimp), Pongo pygmaeus (orangutan), Rattus norvegicus (rat), Tetraodon nigroviridis
(tetradon) and Xenopus tropicalis (frog).
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Fig. 4. Results of the Sanger sequencing and autozygous analysis. (A) Fragments of sequence chromatograms are shown of NDRG4 from a healthy parent (heterozygous mutation),
an affected patient (homozygous mutation) and a control individual (normal homozygous). Black arrows indicate the position of the variant >C. (B) Genotype data for chromosome
16 created by AgileGenotyper and AgileVariantMapper using heterozygous cut-off ratio of 40%. The columns represent the autozygous proﬁle of the father, mother and sons,
respectively. Each row represents the call of a single SNP on chromosome 16 (yellow, heterozygous; black, homozygous; gray, no-call). Note the large run of homozygosity from
w58 Mb to 71 Mb that is exclusively shared by the affected brothers; it is an autozygous region including NDRG4 and RLTPR.
N.D. Linhares et al. / European Journal of Medical Genetics 57 (2014) 643e648648NDRG4 gene, in contrast of the one in RLTPR gene, is located in a
region well conserved throughout evolution, is predicted as dele-
terious and, especially, is associated with tumor development. In
addition, we highlight that we have demonstrated a putative evi-
dence of autosomal recessive causality of IM and, unless other
families are identiﬁed with the mutation, future functional studies
will be needed for conﬁrmation.
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